PURPOSE: The aim of this prospective case series study was to determine the prevalence of HPV-DNA, analyze the E6 mRNA expression, identify intra-type variation in the E6 oncogene in upper aerodigestive tract (UADT) squamous cell carcinoma (SCC), and correlate the presence of HPV-DNA with several clinical parameters and outcome. METHODS: Frozen samples of UADT-SCC were analyzed for the presence and characterization of HPV-DNA and RNA sequences by means of polymerase chain reaction (PCR), reverse transcriptase-PCR, and direct sequencing of amplified products. RESULTS: HPV-DNA sequences were detected in 10% of the tumors, all of which were typed as HPV-16. Positivity for HPV-16 E6/E7 mRNA was observed in five of the eight HPV-positive tumors (62.5%). The HPV-16 E6 L83V variant was present in five cases. Multivariate analysis identified a history of absence of smoking (P = 0.009) as a predictor of HPV-positive tumor. No significant differences in overall and disease free survival curves were observed between patients with HPV-positive tumors and patients with tumors without detectable HPV-DNA. CONCLUSION: Our findings support the etiological participation of HPV-16 in a subset of UADT-SCCs from patients lacking traditional risk factors. The potential prognostic significance of HPV-16 E6 L83V variant in HPV-16 positive UADT-SCCs should be more extensively investigated.
PURPOSE: The aim of this prospective case series study was to determine the prevalence of HPV-DNA, analyze the E6 mRNA expression, identify intra-type variation in the E6 oncogene in upper aerodigestive tract (UADT) squamous cell carcinoma (SCC), and correlate the presence of HPV-DNA with several clinical parameters and outcome. METHODS: Frozen samples of UADT-SCC were analyzed for the presence and characterization of HPV-DNA and RNA sequences by means of polymerase chain reaction (PCR), reverse transcriptase-PCR, and direct sequencing of amplified products. RESULTS: HPV-DNA sequences were detected in 10% of the tumors, all of which were typed as HPV-16. Positivity for HPV-16 E6/E7 mRNA was observed in five of the eight HPV-positive tumors (62.5%). The HPV-16 E6 L83V variant was present in five cases. Multivariate analysis identified a history of absence of smoking (P = 0.009) as a predictor of HPV-positive tumor. No significant differences in overall and disease free survival curves were observed between patients with HPV-positive tumors and patients with tumors without detectable HPV-DNA. CONCLUSION: Our findings support the etiological participation of HPV-16 in a subset of UADT-SCCs from patients lacking traditional risk factors. The potential prognostic significance of HPV-16 E6 L83V variant in HPV-16 positive UADT-SCCs should be more extensively investigated.
Authors: A Del Mistro; L Bonaldi; R Bertorelle; D Minucci; M Franzetti; A Cattelan; E Bonoldi; R Sposetti; A Torrisi; L Chieco-Bianchi Journal: J Low Genit Tract Dis Date: 2001-01 Impact factor: 1.925
Authors: Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz Journal: JAMA Date: 2006-08-23 Impact factor: 56.272
Authors: Tatyana Isayeva; Jie Xu; Camille Ragin; Qian Dai; Tiffiny Cooper; William Carroll; Dan Dayan; Marilena Vered; Bruce Wenig; Eben Rosenthal; William Grizzle; Joshua Anderson; Christopher D Willey; Eddy S Yang; Margaret Brandwein-Gensler Journal: Mod Pathol Date: 2014-12-19 Impact factor: 7.842
Authors: P Boscolo-Rizzo; A Del Mistro; F Bussu; V Lupato; L Baboci; G Almadori; M C DA Mosto; G Paludetti Journal: Acta Otorhinolaryngol Ital Date: 2013-04 Impact factor: 2.124
Authors: Juan Du; Cecilia Nordfors; Anders Näsman; Michal Sobkowiak; Mircea Romanitan; Tina Dalianis; Torbjörn Ramqvist Journal: PLoS One Date: 2012-04-27 Impact factor: 3.240
Authors: Lorena Baboci; Paolo Boscolo-Rizzo; Dana Holzinger; Roberta Bertorelle; Lorena Biasini; Angelika Michel; Markus Schmitt; Giacomo Spinato; Rossana Bussani; Laia Alemany; Giancarlo Tirelli; Maria Cristina Da Mosto; Annarosa Del Mistro; Michael Pawlita Journal: Virol J Date: 2013-11-12 Impact factor: 4.099
Authors: Julio C Betiol; Laura Sichero; Henrique O de Olival Costa; Leandro L de Matos; Maria A Andreoli; Silvaneide Ferreira; Sheila F Faraj; Evandro S de Mello; João S Sobrinho; Lenine G Brandão; Claudio R Cernea; Marco A Kulcsar; Fabio R Pinto; Antonio J Gonçalves; Marcelo B Menezes; Leonardo Silva; Lia M Rossi; Rafaella A Lima Nunes; Lara Termini; Luisa L Villa Journal: Infect Agent Cancer Date: 2016-05-04 Impact factor: 2.965
Authors: Lorena Baboci; Dana Holzinger; Paolo Boscolo-Rizzo; Giancarlo Tirelli; Roberto Spinato; Valentina Lupato; Roberto Fuson; Markus Schmitt; Angelika Michel; Gordana Halec; Maria Cristina Da Mosto; Michael Pawlita; Annarosa Del Mistro Journal: Papillomavirus Res Date: 2016-07-16